[PCSK9 inhibitors on reimbursable prescription: who is eligible?]

Tidsskr Nor Laegeforen. 2023 May 29;143(8). doi: 10.4045/tidsskr.23.0191. Print 2023 May 30.

[Article in Norwegian]

Authors

Anne Grete Semb, Elisabeth Kleivhaug Vesterbekkmo, Kjetil Retterstøl, Dan Atar, Erik E Solberg, Henrik Schirmer, Maja-Lisa Løchen, Anne Kask, Jostein Grimsmo, Charlotte Björk Ingul, John Munkhaugen

PMID: 37254976
DOI: 10.4045/tidsskr.23.0191

No abstract available

MeSH terms

Humans
PCSK9 Inhibitors*

Substances

PCSK9 Inhibitors